Lidocaine (100mg 2%) injected into the carpal joint was used to evaluate the inflammatory response induced by injection (1.5ng) of intra-articular E. coli lipopolysaccharide (LPS) endotoxin. Seventeen male Mangalarga horses aged two to three years were divided into three groups and in all animals was injected 0.9% saline (SAL) in the left carpus (LC), and in the right carpus (RC) one of the following combinations were injected: group A (n=6) LPS plus SAL; group B (n=6) LPS plus lidocaine; group C (n=5) lidocaine plus SAL. Synovial fluid and blood samples were collected immediately before the injection of LPS (T0), and at 1.5 (T1), 3 (T2), 6 (T3), 12 (T4) and 36 hours (T5) after the injection. Clinical and physical variables and cellular and biochemical characteristics of the synovial fluid were evaluated at the same time. The local and systemic inflammatory response was evaluated by measurement of mean serum and synovial fluid TNF-α concentration. A rise in TNF-α concentration in LPS injected joints at 3h in group A and from 1.5h to 3h in group B was observed. It is concluded that LPS triggered an inflammatory process and that lidocaine did not inhibit or attenuate the LPS-induced synovitis nor the synthesis and release of TNF-α.Keywords: horse, synovitis, lipopolysacharide, TNF-α, lidocaine RESUMO Injetou-se lidocaína (100mg 2%) na articulação do carpo para avaliar a resposta inflamatória induzida pela injeção (1,5ng) intra-articular de lipopolissacarídeo (LPS) de E. coli. Utilizaram-se 17 cavalos Mangalarga não castrados, entre dois e três anos, divididos em três grupos. No carpo esquerdo (CE) administrou-se solução fisiológica a 0,9% (SAL) e no carpo direito (CD) uma das seguintes combinações: grupo A (n=6) LPS mais SAL, grupo B (n=6) LPS mais lidocaína e grupo C (n=5) lidocaína mais SAL. Amostras do líquido sinovial e de sangue foram colhidas imediatamente antes da injeção de LPS (T0) e às 1,30 (T1), 3 (T2), 6 (T3), 12 (T4) e 36 horas (T5) após a injeção. Variáveis clínicas e físicas, e características bioquímicas e celulares do líquido sinovial foram avaliadas nos mesmos tempos. A resposta inflamatória local e sistêmica foi mensurada pela concentração do TNF-α no
RESUMOAvaliou-se a inibição da produção do fator de necrose tumoral alfa (TNF-α) devido ao pré-tratamento com antiinflamatório esteroidal (dexametasona) e não esteroidal (diclofenaco sódico) em eqüinos com endotoxemia induzida experimentalmente. Foram utilizados 15 cavalos machos não castrados, distribuídos em três grupos de cinco animais: controle (C), diclofenaco sódico (DS) e dexametasona (DM). A endotoxemia subletal foi induzida pela infusão intravenosa (IV) de 0,1µg/kg/pv de lipopolissacarídeo (LPS) de Escherichia coli 055:B5, administrado em 250ml de solução estéril de cloreto de sódio a 0,9%, durante 15min. Os cavalos do grupocontrole foram tratados com solução de cloreto de sódio a 9% IV. Nos animais do grupo DS, administraram-se, por via oral, 2,2mg/kg de diclofenaco sódico e, nos do grupo DM, 1,1mg/kg de dexametasona IV, respectivamente, 60 e 30min antes da infusão da endotoxina. Mensurou-se, por meio de ensaio de toxicidade com células da linhagem L929, a concentração de TNF-α no soro e no líquido peritoneal às 0, 1¼, 3 e 6 horas após injeção do LPS. No grupo-controle, observou-se aumento significativo de TNF-α sérico, em relação ao valor basal e aos grupos DS e DM, 1,15 horas após a indução da endotoxemia. No líquido peritoneal, as concentrações observadas estavam abaixo daquelas da curva padrão de TNF-α, não havendo diferença entre os grupos (P>0,05).Palavras-chave: eqüino, citocina, TNF-α, endotoxemia, dexametasona, diclofenaco sódico ABSTRACT The inhibition of tumor necrosis factor alpha (TNF-α) production due to pre-treatment with steroidal (dexamethazone) and non-steroidal (sodium diclofenac) anti-inflammatories was studied in horses under experimentally induced endotoxemy. Fifteen stallions were allotted into three groups of five animals each: control (C), sodium diclofenac (SD) and dexamethazone (DM). Sublethal endotoxemy was induced with 0.1µg/kg/bw
Fifteen healthy Mangalarga horses, aged two to three years were used to evaluate the possible beneficial effects of dexamethasone and sodium diclofenac administration during experimental endotoxemia in horses. They were divided into three groups with five animals each: control (C), sodium diclofenac (SD) and dexamethasone (DM). All groups were given 0.1µg of Escherichia coli O55:B5 endotoxin/kg of body weight, intravenous, over 15 minutes, and one of the following preparations: group C - 20ml of 0.9% saline intravenous, 30 minutes before endoxin infusion; group SD - 2.2mg/kg, per os, 60 minutes before endotoxin infusion and group DM - 1.1 mg/kg, intravenous, 30 minutes before endotoxin infusion. No increase in rectal temperature was observed in the SD or DM treated groups. SD did not prevent the significant leukopenia, neutropenia and lymphopenia induced three hours after LPS injection, but DM attenuated these changes. No significant changes in plasma and peritoneal fluid total protein, inorganic phosphorus or glucose concentrations and in total nucleated cell count in peritoneal fluid were observed. SD was effective to prevent the fever and changes in intestinal borborygmi and DM blocked the cellular changes induced by experimental endotoxemia.
The present study aimed to establish the prevalence of orthopedic injuries and main clinical-epidemiological findings in equids referred to the Large Animal Veterinary Teaching Hospital of the Universidade de Brasília (HVET-UNB), during a 2-year period (March 2016 to February 2018. All equids records during the 2-year period were reviewed to select the orthopedic injury cases. Animal records were divided into two groups: traction animals and those participating in other equestrian activities. Definitive diagnosis, reached by means of physical evaluation and ancillary diagnostic (radiography and ultrasonography) methods, showed that 34% (156 cases) of the referred 438 equids, presented some sort of orthopedic disorders. Of these cases, 151 (96.8%) were horses, four (2.6%) mules, and one (0.6%) donkey. Ninety (58%) were traction horses and 66 (42%) participated in other equestrian activities, while 45.5% (71/156) were females and 54.5% (85/156), males. Forelimbs were the most affected (51.9% -81/156), followed by hind limbs (41.1% -64/156) and vertebral column disorders (7% -11/156). Furthermore, 75% (117/156) presented some degree of lameness while 25% (39/156) had no pain or gait alterations. The three major orthopedic injuries were bone disorders (40.4% -63/156), tendinopathies (25.6% -40/156) and arthropathies (13.5% -21/156), while the digital (9% -14/156), muscle (6.4% -10/156) and ligament (5.1% -8/156) injuries were observed less frequently. Total mortality rate reached 32.7% (51/156), and fractures represented the major orthopedic disease leading to euthanasia (80.4% -41/51). The high number of traction equids attended (90 animals -58%) indicates the still frequent use of these animals in large urban centers. The high mortality rate in this category (50% -45/90), representing 90.1% (45/51) of all deaths, reveals the need for developing public policies prohibiting horses from circulating in urban areas while also improving their welfare in the rural area. We reiterate the importance of retrospective studies for identifying risk factors, proposing management changes and creating policies to avoid animal suffering and financial losses.
An 11-year (2007-2018) survey of epidemiological, clinical and pathological findings of horses with primary gastric rupture (PGR) was conducted. Twenty horses presented PGR, nine (45%) horses were clinically evaluated, eleven (55%) were sent dead, and all animals were necropsied. PGR contributed to a prevalence of 0.31% (9/2,868) of all equid attendances, 1.83% (9/491) of colic cases, and 4.1% (20/487) of all equid necropsies. Highly fermentable feed (n=7), gastric impaction (n=4), and perforating gastric ulcer (n=1) were the main causes of PGR; whilst eight horses presented idiopathic gastric rupture. Clinically evaluated horses were tachycardic, tachypneic, febrile, dehydrated, with increased abdominal tension, abnormal mucous membranes and reduced to absent intestinal borborygmi. Improper dietary management, such as the ingestion of low-quality roughage and highly fermentable feedstuffs were detected as the main factors associated with PGR in Midwestern Brazil. It is important to raise awareness in horse owners about proper feed management to minimize PGR.
RESUMOSialolitíase é uma afecção que afeta as glândulas salivares ou seus ductos, caracterizada pela presença de estruturas calcificadas, denominadas de sialolitos, com crescimento lento e gradual, geralmente assintomático, dificultando ou impedindo o fluxo normal de saliva. Devido à ausência de relatos na literatura nacional, descreve-se o caso de uma égua de 15 anos, que apresentava um sialolito de 13cm no ducto parotídico havia mais de dois anos, próximo à crista facial. O diagnóstico foi realizado por meio do exame clínico: visualização do aumento de volume, palpação do sialolito, avaliação odontológica; e de exames complementares: radiografia e ultrassonografia. Optou-se pelo tratamento cirúrgico, através do acesso percutâneo, pois é o mais indicado para cálculos grandes, realizando-se sutura do ducto de Stenon, sem presença de fístulas no pós-operatório. Foi de extrema importância a avaliação e os cuidados odontológicos durante a realização do procedimento, pois as pontas dentárias facilitam a formação dos cálculos. palato e nas regiões bucais. A glândula parótida possui um formato retangular com comprimento de 20 a 25cm, a glândula mandibular tem formato alongado, estreito e com a borda dorsal côncava, sendo menor que a glândula parótida
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.